Belvedere Trading’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Hold
0
272
2024
Q3
Hold
0
225
2021
Q4
Sell
-9,191
Closed -$416K 192
2021
Q3
$416K Buy
+9,191
New +$416K 0.01% 47